TD INVOLVED IN DRUG MONEY LAUNDERING, WSJ REPORT ALLEGES

Severity of the allegations means bank could face stiff fines, business limitations, says analyst

GILD Jan 2025 82.500 call

OPR - OPR Delayed Price. Currency in USD

Add to watchlist

0.7300

-0.0200

(-2.67%)

As of 11:55AM EDT. Market open.

Loading interactive chart...

ACCESSWIRE
Forbes Has Listed Gilead as One of America’s Best Employers for Diversity
NORTHAMPTON, MA / ACCESSWIRE / May 3, 2024 / Gilead Sciences Forbes has listed Gilead as one of America's Best Employers for Diversity. We believe that by championing inclusion and diversity, we not only enrich our workplace but also drive groundbreaking ...
Zacks
The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine
Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine are included in this Analyst Blog.
Zacks
Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More
Deciphera Pharmaceuticals, Inc. (DCPH) and GSK are in focus on acquisition news and Q1 earnings, respectively.